Holen Sie sich die Stockscreener-App
20.26
0.05%
0.01
Finanzdaten der Pelthos Therapeutics Inc.-Aktie (PTHS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
43.07%
15.60
|
10.91 | 16.50 | 7.406 | - |
| Cost Of Revenue |
115.78%
3.61
|
1.673 | 1.672 | 2.316 | - |
Selling, General, and Administrative
|
31.13%
27.67
|
21.10 | 18.47 | - | - |
| Costs And Expenses |
37.23%
32.93
|
23.99 | - | - | - |
| Operating Income/Loss |
32.36%
-17.32
|
-13.09 | -12.00 | -15.36 | -3.2304 |
| Nonoperating Income/Loss |
49.15%
-6.094
|
-11.98 | -16.58 | -1.341 | -0.2185 |
| Income/Loss From Continuing Operations Before Tax |
6.60%
-23.42
|
-25.07 | -28.59 | -16.70 | -3.4489 |
| Income Tax Expense/Benefit |
-
|
- | -6.922 | -0.465 | - |
| Net Income/Loss |
6.60%
-23.42
|
-25.07 | -21.66 | -16.24 | -3.4489 |
| Basic Average Shares |
6.88%
3.5395
|
3.3117 | - | 3.0615 | 0.6405 |
| Diluted Average Shares |
6.88%
3.5395
|
3.3117 | - | 3.0615 | 0.6405 |
| Basic Earnings Per Share |
12.55%
-6.62
|
-7.57 | - | -5.30 | -5.38 |
| Diluted Earnings Per Share |
12.55%
-6.62
|
-7.57 | - | -5.30 | -5.38 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):